Last reviewed · How we verify
NCT07129057
Effect of Mindfulness-Based Protocols on Psychological Parameters and Biological Markers in Populations Exposed to Conditions of Persistent Distress
NA trial testing MBSR program in Distress, Psychological in 100 participants. Completed in 30 September 2024.
30 September 2024
Quick facts
| Lead sponsor | Azienda Unita Sanitaria Locale di Piacenza |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 10 October 2020 |
| Primary completion | 30 September 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- MBSR program
Conditions studied
- Distress, Psychological — all drugs for Distress, Psychological →
Sponsor
Azienda Unita Sanitaria Locale di Piacenza — full company profile →
Who can join
Adults 18 to 65, any sex, with Distress, Psychological. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if a Mindfulness-Based Stress Reduction (MBSR) training can improve the mental health and well-being of healthcare professionals (HCPs) exposed to prolonged severe stress conditions. The main questions it aims to answer are: * Does an 8-week MBSR training lower the cortisol levels of HCPs exposed to prolonged severe stress conditions? * Does an 8-week MBSR training modify the psychological condition of HCPs exposed to prolonged severe stress conditions? Researchers will compare an 8-week MBSR training to no-training to see if MBSR training works to improve the mental health and well-being of HCPs. Participants will: * Partecipate or not partecipate to the MBSR training for 8 weeks * Visit the clinic at baseline, after the 8-week intervention (T1), and at follow-up after 6 months for checkups and tests
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mindfulness Improves Awareness and Cortisol Levels During COVID-19 Lockdown: A Randomised Controlled Trial in Healthcare Workers.
Panzeri A, Bettinardi O, Giommi F, Grassi M, et al · · 2025 · PMID 41095541 · DOI 10.3390/healthcare13192455
Verify or expand the search:
- PubMed search for NCT07129057
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Distress, Psychological
Currently open trials in the same condition.
- NCT07195019 — Women's Wellbeing Study · NA · recruiting
- NCT07209306 — WHO Psychological Interventions for Mental Health Outcomes in Migrants Resettled in Italy: the ADVANCE Trial · NA · recruiting
- NCT06908343 — Psychotherapy Expectations and Distress Among Mental Health Patients and Their Therapists. · recruiting
Other Azienda Unita Sanitaria Locale di Piacenza trials
Trials by the same sponsor.
- NCT07518030 — Telemedicine-guided Uptitration of Therapy in Chronic Heart Failure · NA · recruiting
- NCT06419517 — Pelvic Muscle Training and Electrostimulation to Treat Weak Pelvic Floor · NA · completed
- NCT05981937 — ICG Anastomosis Control in Colon Surgery · completed
- NCT05110859 — QUALITATIVE SURVEY ABOUT NURSES FIRST WORK EXPERIENCE DURING COVID-19 PANDEMIC · unknown
- NCT04683887 — Taping to Control Edema in Patients With Forearm Plaster for Wrist Fracture. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07129057 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Unita Sanitaria Locale di Piacenza
- Last refreshed: 19 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07129057.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing